Regulatory Affairs

FDA strategy and submissions across the 510(k), De Novo, PMA and Breakthrough Device pathways, and the quality system behind them.

What we do

Our work includes

  1. FDA pathway assessment and planning
  2. Pre-Submission strategy and Q-Sub preparation
  3. 510(k), De Novo and PMA submission support, as appropriate to the device
  4. Quality-system requirements and documentation
  5. Coordination of regulatory requirements with clinical and commercial plans
Deliverables

Typical deliverables

The scope depends on the device, intended use, development stage and existing regulatory work.

  • Written pathway assessment and supporting rationale
  • Pre-Submission package and meeting preparation
  • Submission strategy and document plan
  • Quality-system gap assessment and remediation plan
  • Review of design-control and technical documentation
  • Regulatory plan aligned with clinical and reimbursement milestones
Across the product lifecycle

From development to launch and growth

  1. DevelopmentClassification, predicate and pathway assessment; Pre-Submission planning.
  2. Pivotal trialIDE strategy, investigational plan alignment and FDA interactions during the study.
  3. Market entry510(k), De Novo or PMA submission and management of the review.
  4. Launch and growthSupplements, indication expansion, post-approval obligations and change management.

Discuss your regulatory requirements.